Results

Total Results: 3,357 records

Showing results for "aspirin".

2701. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
      March 01, 2012 - is that venous thromboembolism prophylaxis after total hip and knee replacement with warfarin or aspirin … Use of LMWH (compared with aspirin and mechanical device) ? … Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin. … The 2008 ACCP guidelines gave a Grade 1A recommendation against aspirin as TP for any patient group … and the 2010 UK NICE guidelines do not include aspirin as TP for any patient group.1,8 There are no

2702. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cer-222-evidence-summary-health-equity.pdf
      January 01, 2020 - smoking cessation: behavioral and pharmacotherapy interventionsb Adults Cardiovascular disease Aspirin … cancer screening 0 0 0 0 1 Tobacco smoking cessation 0 3 1 2 0 Cardio- vascular disease Aspirin

2703. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/umGzAGWUVDPcnmbdYnHf_a
      March 23, 2022 - smoking cessation,14 screening for hypertension,15 statin use to prevent cardiovascular disease,16 aspirin … Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement

2704. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
      January 01, 2020 - smoking cessation: behavioral and pharmacotherapy interventionsb Adults Cardiovascular disease Aspirin … cancer screening 0 0 0 0 1 Tobacco smoking cessation 0 3 1 2 0 Cardio- vascular disease Aspirin

2705. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
      January 03, 2012 - For example, when Rietbrock et al. considered the comparative effectiveness of warfarin and aspirin … How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with

2706. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
      January 01, 2020 - smoking cessation: behavioral and pharmacotherapy interventionsb Adults Cardiovascular disease Aspirin … cancer screening 0 0 0 0 1 Tobacco smoking cessation 0 3 1 2 0 Cardio- vascular disease Aspirin

2707. Individualized Drug Interaction Alerts - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
      January 01, 2017 - For systemic administration of salicylates, non-acetylated and aspirin are treated separately. … For aspirin, doses greater than 100mg/day are of concern.

2708. NLP to identify and rank clinically relevant information from EHRs in the Emergency Department - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs024541-goss-final-report-2018.pdf
      January 01, 2018 - For example, while aspirin is a highly relevant item for chest pain, aspirin prescriptions rarely contain

2709. Recommendation: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
      July 26, 2022 - adults 33 Interventions for tobacco smoking cessation in adults, including pregnant persons 34 Aspirin … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.

2710. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2711. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2712. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2713. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.cpsi.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2714. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2715. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.monahrq.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2716. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
      August 22, 2018 - how your practice uses clinical guidelines for cardiovascular disease prevention (for example, use of aspirin

2717. Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular Data Registry | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/coronary-stents-outcomes/research
      February 10, 2010 - NS Pre-Procedural Shock 3675 (1.7%) 1746 (3.9%) <0.001 2.1 2.1 NS Pre-Procedural Aspirin … Race, Hispanic 1.138 1.018 1.272 Race, Asian 1.206 1.037 1.401 Contraindication to Aspirin

2718. Learning from Primary Care Meaningful Use Exemplars - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r18hs022701-ornstein-final-report-2014.pdf
      January 01, 2014 - ) who were prescribed beta-blocker therapy 57.9 14.0 Ischemic Vascular Disease (IVD): Use of Aspirin … of age and older with diagnosis of ischemic vascular disease (IVD) who had documentation of use of aspirin … 96.5 (13.9) 54.7 (22.1) 56.2*† (27.2) N/A 48.0† (24.8) Ischemic Vascular Disease (IVD): Use of Aspirin

2719. Fever | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/fever/

2720. Rural Iowa Redesign of Care Delivery with EHR Functions - Grant Final Report Grant ID: 1UC1HS015196-0. (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015196-crandall-final-report-2007.pdf
      January 01, 2007 - were all AMI measures that show mean defect rates of < 9% over the entire 18 month period: AMI 1 - Aspirin … at Arrival; AMI 2 - Aspirin Prescribed at Discharge; AMI 3 - ACE Inhibitor/ARB for LVSD; AMI 5 - Beta … efficacy as there were 3 months in which the defect rates were reduced to zero – once for AMI 2 - Aspirin